BJWTY yields 6.37% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, BJWTY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BJWTY + PFE for your $10,000?
Beijing Enterprises Water Group Limited, together with its subsidiaries, provides water treatment services. The company operates through Sewage and Reclaimed Water Treatment and Construction Services, Water Distribution Services, and Technical and Consultancy Services segments. It constructs sewage and reclaimed water treatment plants, and seawater desalination plants, as well as provides construction services for comprehensive renovation projects in the People's Republic of China, Malaysia, Australia, New Zealand, and the Republic of Botswana. The company also offers sewage and reclaimed water treatment services in Mainland China, the Republic of Singapore, the Portuguese Republic, Australia, and New Zealand; and distributes and sells piped water in Mainland China, the Portuguese Republic, and Australia. In addition, it provides technical and consultancy services; and sells machineries related to sewage treatment and construction services for comprehensive renovation projects in Mainland China and Australia. Further, the company is involved in the licensing of technical know-how related to sewage treatment. Beijing Enterprises Water Group Limited is headquartered in Wan Chai, Hong Kong.
Full BJWTY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.